A detailed history of Gleason Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Gleason Group, Inc. holds 89 shares of ABT stock, worth $10,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89
Previous 114 21.93%
Holding current value
$10,300
Previous $11,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $2,501 - $2,953
-25 Reduced 21.93%
89 $10,000
Q2 2024

Jul 12, 2024

BUY
$100.73 - $112.44 $100 - $112
1 Added 0.88%
114 $11,000
Q1 2024

Apr 12, 2024

BUY
$109.52 - $120.96 $109 - $120
1 Added 0.89%
113 $12,000
Q3 2023

Oct 12, 2023

BUY
$95.53 - $114.62 $95 - $114
1 Added 0.9%
112 $10,000
Q1 2023

Apr 14, 2023

BUY
$96.86 - $114.01 $8,329 - $9,804
86 Added 344.0%
111 $11,000
Q4 2022

Jan 11, 2023

BUY
$95.06 - $111.52 $95 - $111
1 Added 4.17%
25 $0
Q1 2021

Apr 14, 2021

BUY
$108.84 - $128.23 $108 - $128
1 Added 4.35%
24 $3,000
Q2 2020

Aug 27, 2020

SELL
$76.57 - $98.0 $76 - $98
-1 Reduced 4.17%
23 $2,000
Q4 2019

Aug 27, 2020

BUY
$78.51 - $87.4 $1,884 - $2,097
24 New
24 $2,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gleason Group, Inc. Portfolio

Follow Gleason Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gleason Group, Inc. with notifications on news.